NCT02548104View on ClinicalTrials.gov

Analgesic Efficacy of Anterior Femoral, Genicular and Adductor Canal Nerve Block

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

October 1, 2017

Primary Completion Date

November 6, 2023

Study Completion Date

November 6, 2023

Conditions
Pain, Postoperative
Interventions
OTHER

ACB

ultrasound-guided ACB with 0.25% Bupivicaine with 1:200,000 epinephrine 30 ml and ultrasound-guided genicular (IPACK) with normal saline 15 ml

OTHER

ACB + iPACK

ultrasound-guided ACB with 0.25% Bupivicaine with 1:200,000 epinephrine 30 ml and ultrasound-guided genicular (IPACK) with 0.25% Bupivicaine with 1:200,000 epinephrine 15 ml

Trial Locations (1)

90048

Cedars Sinai Medical Center, Los Angeles

All Listed Sponsors
lead

Cedars-Sinai Medical Center

OTHER

NCT02548104 - Analgesic Efficacy of Anterior Femoral, Genicular and Adductor Canal Nerve Block | Biotech Hunter | Biotech Hunter